Comprehensive Segmental Revision System (SRS)
K-Number: K173411 · 2018-02-08
Device Summary
Frequently Asked Questions
What is the Comprehensive Segmental Revision System (SRS)?
Comprehensive Segmental Revision System (SRS) is a medical device that received FDA 510(k) clearance on 2018-02-08. The listed applicant is Biomet Manufacturing Corp. The 510(k) number is K173411.
When did Comprehensive Segmental Revision System (SRS) receive FDA 510(k) clearance?
Comprehensive Segmental Revision System (SRS) received FDA 510(k) clearance on 2018-02-08, under 510(k) number K173411.
Who is the listed applicant for Comprehensive Segmental Revision System (SRS)?
The FDA 510(k) record lists Biomet Manufacturing Corp as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for Comprehensive Segmental Revision System (SRS)?
The FDA product code for Comprehensive Segmental Revision System (SRS) is PHX.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Biomet Manufacturing Corp as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: PHX)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.